“Wearable technology has grown in popularity with some people using devices to share health data with their physicians,” ...

Please provide your email address to receive an email when new articles are posted on . Approximately 54% of individuals in the U.S. are affected by a neurological disorder, with headache the most ...

Researchers in Taiwan tried to examine whether using acetaminophen during pregnancy leaves children at greater risk of ...

Neurological disorders affect over a third of the global population, presenting immense challenges for patients worldwide. Merz Therapeutics, a leading player in specialty neurology, aims to deliver ...

The study found that participants using GLP-1s were less likely to develop substance-use disorders or to have bad outcomes like overdosing. This comes at a time when manufacturers of these medications ...

Incubated by Atlas Venture, the biotech startup is advancing a daily pill it sees potentially helping people with dystonia or Parkinson's disease regain control of movement.

(NewsNation) — More than 1 in 3 people are living with a neurological condition, the World Health Organization found, and countries aren’t prepared to deal with it. The WHO’s Global status report on ...

Explore what is driving progress in neurological biomarker research today, from emerging technologies to clinical translation.

This biotech specializes in therapies for neurological disorders, advancing a diverse pipeline through late-stage trials and collaborations.

One in seven Indians is affected by mental health disorders, while several states continue to face a treatment gap ranging from 70 to 90 per cent as discussed in the post-budget webinar breakout ...